Abbott Laboratories to pay $670 million over premature-infant formula claims
Abbott Laboratories will pay $670 million to settle cases and claims concerning its formula for premature babies. The headline does not specify the number of cases or affected patients.
By DoomRadar · Published on DoomRadar .
Why it matters
The settlement concerns the safety and liability of a product used by medically vulnerable infants.
Related source links
These links were collected with this event. Recorded source dates may reflect when a link was found. Article publication dates are shown only when available from the source. Open the originals for their full context.
- Abbott Laboratories to pay $670 million to settle cases, claims over its formula for premature babies ↗dailypress.com · Recorded source date: Aug 21, 2026, 3:31 AM UTC
AI-assisted, source-based analysis. Methodology · Report a correction